Adjuvant therapy for advanced renal cell carcinoma.

Meissner, Matthew A; McCormick, Barrett Z; Karam, Jose A; Wood, Christopher G

Meissner, Matthew A; McCormick, Barrett Z; Karam, Jose A; Wood, Christopher G.

Affiliation

Meissner MA; a Department of Urology , The University of Texas MD Anderson Cancer Center , Houston , Texas , USA.
McCormick BZ; a Department of Urology , The University of Texas MD Anderson Cancer Center , Houston , Texas , USA.
Karam JA; a Department of Urology , The University of Texas MD Anderson Cancer Center , Houston , Texas , USA.
Wood CG; a Department of Urology , The University of Texas MD Anderson Cancer Center , Houston , Texas , USA.

Expert Rev Anticancer Ther ; 18(7): 663-671, 2018 07.

Article in En | MEDLINE | ID: mdl-29707987

Subject(s)

Carcinoma, Renal Cell/therapy; Kidney Neoplasms/therapy; Molecular Targeted Therapy; Cancer Vaccines/administration & dosage; Carcinoma, Renal Cell/pathology; Chemotherapy, Adjuvant/methods; Humans; Immunotherapy/methods; Kidney Neoplasms/pathology; Neoplasm Recurrence, Local; Patient Selection; Prognosis; Survival Rate

Key words

Adjuvant therapy; cytokine therapy; immune checkpoint inhibitors; immunotherapy; renal cell carcinoma; vaccine therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Molecular Targeted Therapy / Kidney Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Expert Rev Anticancer Ther Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2018 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google